- Home
- ARVN vs OCSL Comparison
ARVN vs OCSL Comparison
Compare ARVN & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- OCSL
- Stock Information
- Founded
- ARVN 2015
- OCSL 2007
- Country
- ARVN United States
- OCSL United States
- Employees
- ARVN N/A
- OCSL N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- OCSL Finance: Consumer Services
- Sector
- ARVN Health Care
- OCSL Finance
- Exchange
- ARVN Nasdaq
- OCSL Nasdaq
- Market Cap
- ARVN 1.4B
- OCSL 1.3B
- IPO Year
- ARVN 2018
- OCSL 2008
- Fundamental
- Price
- ARVN $18.57
- OCSL $15.72
- Analyst Decision
- ARVN Strong Buy
- OCSL Hold
- Analyst Count
- ARVN 13
- OCSL 9
- Target Price
- ARVN $63.00
- OCSL $17.29
- AVG Volume (30 Days)
- ARVN 860.7K
- OCSL 867.4K
- Earning Date
- ARVN 02-25-2025
- OCSL 02-04-2025
- Dividend Yield
- ARVN N/A
- OCSL 13.99%
- EPS Growth
- ARVN N/A
- OCSL N/A
- EPS
- ARVN N/A
- OCSL 0.72
- Revenue
- ARVN $161,100,000.00
- OCSL $381,665,000.00
- Revenue This Year
- ARVN $239.85
- OCSL N/A
- Revenue Next Year
- ARVN N/A
- OCSL N/A
- P/E Ratio
- ARVN N/A
- OCSL $21.84
- Revenue Growth
- ARVN 1.07
- OCSL 0.63
- 52 Week Low
- ARVN $17.08
- OCSL $14.89
- 52 Week High
- ARVN $53.08
- OCSL $21.64
- Technical
- Relative Strength Index (RSI)
- ARVN 43.53
- OCSL 58.39
- Support Level
- ARVN $17.35
- OCSL $14.89
- Resistance Level
- ARVN $21.00
- OCSL $15.43
- Average True Range (ATR)
- ARVN 1.18
- OCSL 0.17
- MACD
- ARVN 0.12
- OCSL 0.10
- Stochastic Oscillator
- ARVN 38.01
- OCSL 86.46
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.